CAS: 1215115-03-9
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | (2E)-3-[5-(4-tert-Butylbenzenesulfonamido)-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide REF: 3D-QYB11503CAS: 1215115-03-9 | Min. 95% | Prezzo su richiesta | Ven 27 Dic 24 |
 | KH-3 REF: TM-T62398CAS: 1215115-03-9 | - - - | 1.158,00 €~2.279,00 € | Mer 15 Gen 25 |
![(2E)-3-[5-(4-tert-Butylbenzenesulfonamido)-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide](https://static.cymitquimica.com/products/3D/thumb/QYB11503.jpg)
(2E)-3-[5-(4-tert-Butylbenzenesulfonamido)-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide
CAS:1215115-03-9
Please enquire for more information about (2E)-3-[5-(4-tert-Butylbenzenesulfonamido)-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide including the price, delivery time and more detailed …
Purezza:
Min. 95%
Peso molecolare:
430.5 g/mol
Ref: 3D-QYB11503
| 25mg | Prezzo su richiesta | ||
| 250mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024
KH-3
CAS:1215115-03-9
KH-3: HuR inhibitor, IC50 0.35 μM, halts cell growth, blocks HuR-FOXQ1 mRNA, curbs breast cancer …
Formula:
C21H22N2O4S2
Colore e forma:
Solid
Peso molecolare:
430.54
Ref: TM-T62398
| 25mg | 1.158,00 € | ||
| 50mg | 1.505,00 € | ||
| 100mg | 2.279,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 15 Gennaio 2025
